Intestinal Fatty Acid Binding Protein in Very Low Birth Weight Infants With Meconium Obstruction

Meconium Obstruction of Prematurity Clinical Trial

Official title:
The Clinical Utility of Urine Intestinal Fatty Acid Binding Protein in the Management of Very Low Birth Weight Infants With Meconium Obstruction

Status Completed

Clinical Trial Summary

Urinary intestinal fatty acid binding protein (i-FABP), a marker of intestinal mucosal cell damage, has recently been proposed as a clinically useful measure in the early detection of necrotizing enterocolitis (NEC). However, there are no data on urinary i-FABP in meconium obstruction of prematurity (MOP). This study aimed to evaluate urinary i-FABP in MOP patient as a marker for early detection.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Birth Weight
Cystic Fibrosis
Intestinal Obstruction
Meconium Obstruction of Prematurity

Clinical Trial Details

NCT number	NCT02864446
Study type	Observational
Source	Seoul National University Hospital
Contact
Status	Completed
Phase	N/A
Start date	October 2012
Completion date	September 2015

View Details

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT06048614` - Saline Enema Administration in Meconium Obstruction of Prematurity and Impact on the Resolution, Feeds, Microbiome, and Gut-brain Axis.	N/A
	Completed	`NCT03513640` - Risk Factors of Meconium Obstruction and Respiratory Distress Syndrome in Preterm Infants